Clinical safety, tolerance, and plasma levels of the oral anticholinesterase 1,2,3,4-tetrahydro-9-aminoacridin-1-oL-maleate (HP 029) in Alzheimer's disease: preliminary findings.
about
Velnacrine for Alzheimer's diseaseEvaluation of HP 029 (velnacrine maleate) in Alzheimer's disease.Tacrine for Alzheimer's disease.Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection.Research on the cognitively impaired: lessons and warnings from the emergency research debate.Alzheimer's patients should be included in phase I clinical trials to evaluate compounds for Alzheimer's disease.Implications of the study population in the early evaluation of anticholinesterase inhibitors for Alzheimer's disease.Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease.The treatment of Alzheimer's disease
P2860
Q24247210-B6352467-C68D-4AF7-B1D1-FB8FEF611DFCQ33296510-871C1DCC-D5A0-4796-BA3C-D5633533EB57Q33908605-15DE2BDF-F5A8-495F-ADF5-785BF838F2BCQ36648773-002CA12E-9C0F-4833-95CE-31F16AC965E5Q41430183-87AD9530-7F82-423C-A20B-B1879BE38989Q46551892-192671AA-23E8-41C2-8604-EE1404852420Q46689318-A401424A-7AB8-4B0D-8D60-AB75D697C849Q48586931-A9EC4F0E-1038-4401-B0F0-50D2BE6BEFF2Q57526641-D1994134-9B02-4CC7-9079-E24C5356FC66
P2860
Clinical safety, tolerance, and plasma levels of the oral anticholinesterase 1,2,3,4-tetrahydro-9-aminoacridin-1-oL-maleate (HP 029) in Alzheimer's disease: preliminary findings.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Clinical safety, tolerance, an ...... disease: preliminary findings.
@ast
Clinical safety, tolerance, an ...... disease: preliminary findings.
@en
type
label
Clinical safety, tolerance, an ...... disease: preliminary findings.
@ast
Clinical safety, tolerance, an ...... disease: preliminary findings.
@en
prefLabel
Clinical safety, tolerance, an ...... disease: preliminary findings.
@ast
Clinical safety, tolerance, an ...... disease: preliminary findings.
@en
P2093
P2860
P1476
Clinical safety, tolerance, an ...... disease: preliminary findings.
@en
P2093
P2860
P304
P356
10.1002/J.1552-4604.1990.TB03620.X
P577
1990-06-01T00:00:00Z